Berlin - Die Umweltorganisation Greenpeace fordert eine Zulassungssteuer auf Neuwagen mit Verbrennungsmotor. Einnahmen aus der Abgabe könnten eine neue Kaufprämie für E-Autos finanzieren.Neue Berec...
Nippon Steel President Tadashi Imai said filing a lawsuit against the U.S. government is one of the "important options", Nippon Television reported on Monday, after President Joe Biden blocked its proposed purchase of U.S. Steel .
Vertivs strong portfolio & rich partnerships are driving growth, but fierce competition, inflation, and valuation concerns demand a cautious approach in 2025.
BURLs growth initiatives, including the Burlington 2.0 transformation and store expansion plan, are driving profitability and long-term value creation.
Treace Medical announces the limited market release of the Percuplasty Percutaneous 3D Bunion Correction System, targeting the in-demand bunion surgery market.
In 2025, the artificial intelligence (AI) theme is looking to be powerful yet again thanks to snowballing demand. And these three stocks will keep investors riding the wave.
Although higher mortgage rates and land/labor costs pose risks, better operating leverage and marketing strategies are likely to drive homebuilders like NVR, PHM and TMHC.
Rising gold prices and solid demand bode well for the Zacks Mining - Gold industry. We suggest keeping tabs on stocks like AEM, FNV, KGC, EQX and GROY.
AI can be a fantastic tool for your personal finances, but it doesnt take the place of real (a.k.a. human) advisors. Meredith offers some dos and donts for using this impressive yet impersonal technology in your money matters.
The mean of analysts price targets for Ovintiv (OVV) points to a 39.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The U.S. auto market in 2025 holds promise with rising EV adoption, better affordability and economic strength, but policy shifts and margin concerns persist.
CVS Healths Medicaid business is experiencing medical cost pressure from higher-than-expected acuity following the resumption of member redeterminations.
PBAs strong financials, acquisitions and dividends make it appealing, but risks such as asset volatility, regulatory challenges and high capital costs remain.
Our time-tested methodologies helped investors navigate the market well last week. Here are some of our key performance data from the past three months.
KBHs fourth-quarter fiscal 2024 results are likely to benefit from macro tailwinds amid high costs. Dive in to get a better picture of the stock ahead of earnings.
Atmos (ATO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
EQNRs Hammerfest LNG plant is the largest export facility for liquefied natural gas in Europe. It contributes to about 5% of all gas exports from Norway.
EXELs shares surge 50% in a year on the back of the strong performance of its lead drug Cabometyx. We are optimistic about the stock as we believe there is room for further growth.
Given PLTRs remarkable surge in stock price, its essential to evaluate its current standing and determine whether it remains a compelling investment choice.
Todays Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Amgen Inc. (AMGN), as well as two micro-cap stocks PrimeEnergy Resources Corporation (PNRG) and FONAR Corporation (FONR).